Regeneron's product sales were down billions of dollars in Q1 compared to the most recent period.
The latest net profit margin isn't nearly as impressive as it was just a quarter ago.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,